|
Market Closed -
London S.E.
11:35:10 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 1,918.50 GBX | -0.10% |
|
+5.56% | +5.15% |
| Aug. 21 | WINNERS & LOSERS: Hunting falls on outlook cut; miners rise | AN |
| Aug. 20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| Market Cap | 76.87B 105B 89.75B 83.98B 144B 10,025B 146B 992B 387B 5,036B 393B 385B 16,657B | P/E 2026 * |
14.5x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 96.07B 131B 112B 105B 180B 12,529B 183B 1,240B 484B 6,294B 492B 481B 20,818B | EV / Sales 2026 * |
2.83x | EV / Sales 2027 * | 2.62x |
| Free-Float |
92.75% | Yield 2026 * |
3.63% | Yield 2027 * | 3.91% |
Last Transcript: GSK plc
| 1 day | -0.10% | ||
| 1 week | +5.56% | ||
| Current month | -0.67% | ||
| 1 month | +1.35% | ||
| 3 months | +0.21% | ||
| 6 months | -13.31% | ||
| Current year | +5.15% |
| 1 week | 1,829 |  | 1,937 |
| 1 month | 1,803 | | 2,096 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,440.29 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/29/26 | Sell | Executive/Senior Manager | -38,000 | 0.0009% | ||
| 7/22/26 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 7/14/26 | Buy | Chief Technology Officer | 660 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | +5.56% | +28.54% | +42.39% | 105B | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | |
| Average | +1.15% | +5.03% | +31.03% | +52.11% | 390.46B | |
| Weighted average by Cap. | +1.10% | +5.10% | +43.88% | +71.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.94B 46.26B 39.63B 37.08B 63.7B 4,427B 64.54B 438B 171B 2,224B 174B 170B 7,355B | 35.54B 48.44B 41.49B 38.82B 66.69B 4,634B 67.57B 459B 179B 2,328B 182B 178B 7,700B |
| Net income | 5.44B 7.41B 6.35B 5.94B 10.2B 709B 10.34B 70.16B 27.36B 356B 27.82B 27.21B 1,178B | 6.48B 8.84B 7.57B 7.08B 12.17B 846B 12.33B 83.69B 32.64B 425B 33.19B 32.46B 1,405B |
| Net Debt | 19.2B 26.17B 22.42B 20.98B 36.03B 2,504B 36.51B 248B 96.64B 1,258B 98.27B 96.13B 4,160B | 16.37B 22.32B 19.12B 17.89B 30.73B 2,135B 31.13B 211B 82.41B 1,073B 83.8B 81.97B 3,548B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | GBX 1,918.50 | -0.10% | 4,820,018 |
| 26-08-20 | GBX 1,920.50 | +0.23% | 8,381,344 |
| 26-08-19 | GBX 1,916.00 | +1.48% | 4,490,573 |
| 26-08-18 | GBX 1,888.00 | +1.97% | 3,706,955 |
| 26-08-17 | GBX 1,851.50 | +1.87% | 3,969,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
